Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-12-20 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-01-11 |
| Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Parties | HETERO LABS LIMITED UNIT-V | ||
| Patents | 7,465,800; 7,468,363; 7,855,217; 8,741,929 | ||
| Attorneys | GARRETT E. BROWN , JR. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-12-19 | 1 | United States Patent Nos. 7,465,800 (the “’800 patent”), 7,855,217 (the “’217 patent”), 7,468,363 (… (the “’363 patent”), and 8,741,929 (the “’929 patent”) (collectively, “the patents-in-suit”) owned … 1. This is an action for patent infringement under the patent laws of the United States, 35 … The Patents-in-Suit 10. On December 16, 2008, the United States Patent and Trademark…of the ’800 patent, constitutes infringement of one or more of the claims of that patent under 35 U.S.C | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
